15 mg: the maximum dose The highest approved dose produces the greatest average weight loss, 22.5% in SURMOUNT-1, but the incremental benefit over 10 mg is modest
This section confirms that they are not enrolled in, planning to enroll, or eligible for Medicaid or Medicare Extra Help/LIS
Our team provides in-office education on administering weekly injections and closely monitors your progress, adjusting dosing as needed to ensure safe, effective weight loss
Sources: FDA Drug Safety Communication, Jan 13, 2026 FDA prescribing labels: Ozempic, Wegovy, Mounjaro, Zepbound EMA / PRAC statement on NAION, June 6, 2025 UK MHRA Drug Safety Update on semaglutide & NAION Endocrine Society of India Clinical Practice Guidelines for Obesity, 2025 Disclaimer: This content is for educational purposes only and is not medical advice, diagnosis, or treatment